INVO Bioscience: INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time

SARASOTA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO Fertility" or the "Company"), a healthcare fertility focused company, reminds shareholders to vote their shares online ahead of the upcoming annual meeting of shareholders (the "Annual Meeting") to be held on June 25, 2025 at 12:00 p.m. Eastern Time. The Board of Directors (the "Board") unanimously recommends that the Company's shareholders vote "FOR" all proposals. Only shareholders of record as of the close of business on May 21, 2025 will be entitled to notice of, and to vote, at the Annual Meeting."We encourage shareholders to cast their votes for our upcoming annual meeting," said Steve Shum, CEO of INVO Fertility. "Your vote will help support our growth strategies, including the acquisition of established, profitable fertility clinics and the expansion of our INVOcell technology, further allowing us to take advantage of favorable market trends and policy developments and continue to capitalize on the current momentum. Specifically, we are currently experiencing a very robust pipeline of potential transactions for complementary and accretive revenue-generating services and technologies. With our existing clinic operations along with our now leaner corporate infrastructure, we believe our current foundation has never been in a stronger position to further leverage our public company platform to structure favorable win-win transactions to drive revenues, reach profitability and deliver strong shareholder value from current levels. We sincerely appreciate the support of all shareholders." All votes are important, regardless of the number of shares owned. Shareholders as of the Annual Meeting's record date of May 21, 2025, will be entitled to vote at the Annual Meeting. Shareholders are encouraged to read about the proposals in the Company's Definitive Proxy Statement on Schedule 14A that was filed with ...Full story available on Benzinga.com